OncoCipherPATIENT
Educational & Guideline Reference Notice: Unranked FDA-label and national guideline option categories and recruiting clinical trials for discussion with a licensed oncologist. Protocol drug dosing and autonomous treatment prescriptions are excluded.

OncoCipher Curated Oncology Reference & Clinical Trial Directory

Explore 248 source-cited FDA-label and guideline option categories and 970 typed recruiting clinical trials across 5 major solid-tumor indications—available to patients in plain language and to personal AI assistants via native MCP (https://patient.oncocipher.com/mcp).

Breast Cancer

Invasive Breast Carcinoma (HR+, HER2+, HER2-Low, & Triple-Negative)

Biomarker-guided reference covering hormone receptor (ER/PR), HER2 / HER2-low IHC/ISH, BRCA1/2, PIK3CA, AKT1/PTEN, ESR1, and recruiting clinical trials.

64 Unranked Reference Options 43 Recruiting Trials

Browse Options & Citations · Browse Clinical Trials

Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Carcinoma (Adenocarcinoma & Squamous)

Molecularly stratified reference covering EGFR, ALK, ROS1, BRAF V600E, KRAS G12C, MET exon 14, RET, HER2, NTRK, PD-L1 expression, and recruiting trials.

92 Unranked Reference Options 46 Recruiting Trials

Browse Options & Citations · Browse Clinical Trials

Colorectal Cancer (CRC)

Colon and Rectal Adenocarcinoma

Source-cited reference covering MMR/MSI status, KRAS/NRAS, BRAF V600E, HER2 amplification, sidedness, surgical/systemic settings, and recruiting trials.

34 Unranked Reference Options 507 Recruiting Trials

Browse Options & Citations · Browse Clinical Trials

Ovarian, Fallopian Tube & Primary Peritoneal Cancer

Epithelial Ovarian / High-Grade Serous Carcinoma (HGSC)

Source-cited reference covering germline/somatic BRCA1/2, HRD status, Folate Receptor-alpha (FRa), platinum interval, maintenance categories, and recruiting trials.

22 Unranked Reference Options 342 Recruiting Trials

Browse Options & Citations · Browse Clinical Trials

Cutaneous & Mucosal Melanoma

Melanoma (Stage 0–IV & Unresectable)

Source-cited reference covering BRAF V600 status, NRAS/KIT, nodal staging, neoadjuvant/adjuvant and checkpoint/targeted therapy categories, and recruiting trials.

36 Unranked Reference Options 32 Recruiting Trials

Browse Options & Citations · Browse Clinical Trials

Use With Your Personal AI Assistant (MCP)

Point Claude, ChatGPT, Gemini, or OpenClaw to https://patient.oncocipher.com/mcp. You can ask your AI to set up your OncoCipher account, upload a local folder of pathology/genomic PDFs or faxes alongside your personal notes, and return your personalized interactive report link.